ArticleScientific reports2025
Multi scale deep learning quantifies Ki67 index in breast cancer histopathology images.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Automated Assessment of Ki-67 Labeling Index Using Cell-Level Detection and Classification in Whole-Slide Images.Diagnostics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The Ki67 proliferation index (PI) serves as a crucial prognostic indicator in clinical settings, widely utilized for evaluating breast cancer progression and forecasting chemotherapy efficacy. Nonetheless, conventional manual PI estimation methods are plagued by high subjectivity, time inefficiency, and limited reproducibility. Despite notable advancements in deep learning for Ki67 PI computation, current approaches face challenges in concurrently capturing local cellular morphological features and global tumor proliferation data, particularly when addressing issues like complex backgrounds, staining variability, tumor heterogeneity, and noise in low-resolution images. In response, we introduce Kpi-Net, a multi scale deep learning framework built on U-Net, designed to precisely quantify the Ki67 index in breast cancer pathology images. Initially, we develop a Residual Dilated Multi Scale Module (RDMS Module) that utilizes multi-branch dilated convolutions and residual connections to capture both local and global information, while integrating a Transformer Block to bolster global modeling, effectively mitigating missed and erroneous detections arising from irregular cell distribution. Next, we introduce the High-level Screening-Convolutional Block Attention Module Feature Pyramid Networks (HS-CBAM-FPN), incorporating channel and spatial attention mechanisms alongside the Selective Feature Fusion with CBAM (SFF-CBAM) to facilitate effective integration of multi-level features. Lastly, we apply the watershed algorithm to feature maps, refining cell cluster segmentation via distance transformation and local maximum detection, which improves the precision of Ki67 index computation. Comprehensive experimental results indicate that Kpi-Net surpasses current leading methods in metrics like F1 score and root mean square error (RMSE), highlighting its potential for accurate Ki67 index computation and precise cell detection, thereby offering a dependable tool for accurate breast cancer diagnosis and therapeutic decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.